Neurofilament Light Chain ,

Neurofilament light chain: Bjorn Oskarsson, M.D.

Mayo Clinic Laboratories

Serum neurofilament light chain levels as a biomarker in MS

Serum Neurofilament Light Chain (sNfL) in MS with Ben Thrower, M.D.

Multiple Sclerosis Foundation

Debate: Neurofilament light chain is the most important biomarker in the MND/ALS field

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS

Neurology Journal

Neurofilament Light Chain: A Mulitiple Sclerosis Biomarker (Dr. Marwa Kaisey Interview)

Dr. Brandon Beaber

The association between neurofilament light chain and non-motor PD symptoms

Successes in Parkinson’s disease: seeding assays and neurofilament light chains

Assessing the role of measuring plasma neurofilament light levels in ALS

Neurofilament Light Chain: Hot Topics

Powering Precision Health Info

Neurofilament Light Chain (NfL) as a Biomarker in Neurological Disorders

Benjamin Ricard

Understanding the Role of Neurofilament in ALS

Neurofilament Light Chain in Neurodegenerative Diseases – Status Update

Serum NfL: a first-in-class biomarker paving the way towards precision medicine in MS

Neurofilament light chain as a biomarker in pediatric MS

Neurofilament Light Chain Levels Predictor of Radiologically Syndrome to Multiple Sclerosis

Neurology Today

Interpretation of serum NfL depends on the selection of a reference population

C-Path Neuroscience Program Webinar | Neurofilament Light Chain in Neurodegenerative Disease

Critical Path Institute

Neurofilament Light Chain: Real World Applicability in Multiple Sclerosis

Powering Precision Health Info

Moving Science Podcast:What is the clinical value of Neurofilament light (NfL) in MS Care today? 2/2